期刊文献+

老年性骨质疏松症及其干预治疗对牙种植体骨整合过程的影响 被引量:1

原文传递
导出
摘要 牙种植体-骨整合取决于种植部位的骨质量和骨数量。骨质疏松症可以引起皮质骨变薄,松质骨骨小梁减少、变细,Ⅰ型胶原含量降低,因此被认为是影响种植体-骨整合的重要原因之一。如何提高骨质疏松症患者牙种植体-骨整合率成为当前口腔种植领域的热点。本文试从骨质疏松症的诊断、对骨整合作用的影响以及药物干预等方面,探讨老年骨质疏松症对牙种植的影响及预防措施。
作者 王莉 陈建钢
出处 《临床口腔医学杂志》 2008年第11期694-696,共3页 Journal of Clinical Stomatology
  • 相关文献

参考文献17

  • 1Bonjour JP, Ammann P, Rizzoli R. Importance of preclinical studies in the development of drugs for treatment of osteoporosis: A review related to the 1998 WHO guidelines [J]. Osteoporosis International, 1999,9 (5) :379-393.
  • 2周丽珍,向青,刘忠厚.合理使用骨质疏松症诊疗的骨代谢标志物指南(2004年版)[J].中国骨质疏松杂志,2004,10(4):397-404. 被引量:21
  • 3和田诚基,胡宜,李军.骨代谢标志物和骨质疏松症[J].日本医学介绍,2003,24(2):84-84. 被引量:5
  • 4Ravn P, Overgaard K, Spencer EM. Insulin-like growth factors Ⅰ and Ⅱ in healthy women with and without established osteoporosis [J]. Eur J Endocrinol, 1995,132.. 313-319.
  • 5Tanaka H, Ogasa H, Barnes J. Actions of bFGF on mitogenic activity and lineage expression in rat osteoprogenitor cells: effect of age [J]. Mol Cell Endocrinol, 1999, 150:1-10.
  • 6Mori H, Manabe M, Kurachi Y,et al. Osseointegration of dental implants in rabbit bone with low mineral density [J]. J of Oral and Maxillofacial Surgery, 1997,55: 351-362.
  • 7JA Shibli, KCDS Aguiar, L Melo, et al. Histological comparison between implants retrieved from patients with and without osteoporosis [J]. Int J Oral Maxillofac Surg, 2008,37: 321-327.
  • 8杨黎娟,张秀珍.雌激素抗骨质疏松的研究进展[J].国外医学(内科学分册),2004,31(2):84-87. 被引量:9
  • 9高劲松,刘雅梅,周延民.激素对种植体-骨整合的促进作用的研究进展[J].中华老年口腔医学杂志,2006,4(3):177-179. 被引量:4
  • 10MC Qi, XQ. Zhou, JHu, et al. Oestrogen replacement therapy promotes bone healing around dental implants in osteoporotic rats [J] .Int J Oral Maxillofac Surg, 2004, 33: 279-285.

二级参考文献133

共引文献83

同被引文献8

  • 1王艺,贾国栋,潘可风,黄远亮,冯波,杨蔺.阿仑膦酸钠与雌激素对实验性骨质疏松大鼠种植体骨结合作用的比较研究[J].现代口腔医学杂志,2006,20(5):526-530. 被引量:8
  • 2Kelly J.Lin A. Wang cr.a al. Vitamin D and bone physiology: demonstration of vitamin D deficiency in an implant osseointegration rat model Cl)' J Prosthodont , 2009. 18 (6) : 473-478.
  • 3Alvim-Pereira F.Montes CC. Thome C.el al. Analysis of association of clinical aspects and vitamin D receptor gene polymorphism with dental implant loss Cl)' Clin Oral Implants Res, 2008, 19 (8) :786- 795.
  • 4Li Y. Cao Y. Song G. el a1. Additive effects of estrogen replacement therapy and bisphosphonates on osseointegration of hydroxyapatite-coated titanium screws in ovariectomized rats D)' Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010.109 (5): 700-705.
  • 5Sairanen Ss Karkkainen M,TlihteliiR,et al. Bone mass and markers of bone and calcium metabolism in postmenopausal women treated with I, 25-dihydroxyvitamin D (CalcitrioJ) for four years D]. Calcif Tissue Int, 2000, 67 (2): 122-127.
  • 6Shiraishi A,Takeda Ss Masaki Tv et al. Alfacalcidol inhibits bone resorption and stimulates formation in an ovariectomized rat model of osteoporosis: distinct actions from estrogen[j]. J Bone Miner Res, 2000,15(4):770-779.
  • 7Tsurukami H, Nakamura T, Suzuki K, el al. A novel synthetic vitamin D analogue, 2 beta- (3-hydroxypropoxy) 1 alpha, 25-dihydroxyvita- min D3 (ED-71),increases bone mass by stimulating the bone tbmaation in normal and ovariectomized rats [J]. Calcif Tissue Int, 1994, 54 (2) : 142-149.
  • 8李剑平,戚孟春,石燕萍,于静,胡静.唑来膦酸局部治疗对骨质疏松时自体髂骨移植内种植体骨结合的影响[J].口腔医学研究,2011,27(1):12-15. 被引量:7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部